Evidence map›Paper›PMID 21901111›Full record

ArticlePLoS genetics2011

Increased RPA1 gene dosage affects genomic stability potentially contributing to 17p13.3 duplication syndrome.

Emily Outwin, Gillian Carpenter, Weimin Bi, Marjorie A Withers, James R Lupski, Mark O'Driscoll

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Modeling the study of DNA damage responses in mice.Methods in molecular biology (Clifton, N.J.) · 2015
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Diseases associated with defective responses to DNA damage.Cold Spring Harbor perspectives in biology · 2012
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Emily OutwinHuman DNA Damage Response Disorders Group, Genome Damage and Stability Centre, University of Sussex, Brighton, United Kingdom.
Gillian Carpenter
Weimin Bi
Marjorie A Withers
James R Lupski
Mark O'Driscoll
University of Sussex · GBBaylor College of Medicine · USBaylor Genetics · US

Funding

ZOLENDRONIC ACID IN CHILDREN W/ SEVERE OSTEOGENESIS IMPERFECTAM01RR000188 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI SHEARER, WILLIAM THOMAS · 1985 to 2011
$30.6M
Nonrecurrent rearrangements, genome architecture and neurodegenerative disease.R01NS058529 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI LUPSKI, JAMES R. · 2009 to 2017
$5.0M
Cancer Research UKMedical Research Council G0700733NCRR NIH HHS M01 RR000188NINDS NIH HHS R01 NS058529
6 · The paper itself

Abstract

A novel microduplication syndrome involving various-sized contiguous duplications in 17p13.3 has recently been described, suggesting that increased copy number of genes in 17p13.3, particularly PAFAH1B1, is associated with clinical features including facial dysmorphism, developmental delay, and autism spectrum disorder. We have previously shown that patient-derived cell lines from individuals with haploinsufficiency of RPA1, a gene within 17p13.3, exhibit an impaired ATR-dependent DNA damage response (DDR). Here, we show that cell lines from patients with duplications specifically incorporating RPA1 exhibit a different although characteristic spectrum of DDR defects including abnormal S phase distribution, attenuated DNA double strand break (DSB)-induced RAD51 chromatin retention, elevated genomic instability, and increased sensitivity to DNA damaging agents. Using controlled conditional over-expression of RPA1 in a human model cell system, we also see attenuated DSB-induced RAD51 chromatin retention. Furthermore, we find that transient over-expression of RPA1 can impact on homologous recombination (HR) pathways following DSB formation, favouring engagement in aberrant forms of recombination and repair. Our data identifies unanticipated defects in the DDR associated with duplications in 17p13.3 in humans involving modest RPA1 over-expression.

Indexed as

Gene DosageGenomic Instability1-Alkyl-2-acetylglycerophosphocholine EsteraseAnimalsAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsCHO CellsChromosome DuplicationChromosomes, Human, Pair 17CricetinaeDNA Breaks, Double-StrandedDNA DamageGene ExpressionHumansMicrotubule-Associated ProteinsMosaicism1-Alkyl-2-acetylglycerophosphocholine EsteraseAtaxia Telangiectasia Mutated ProteinsATR protein, humanCell Cycle ProteinsMicrotubule-Associated ProteinsPAFAH1B1 protein, humanProtein Serine-Threonine KinasesRad51 RecombinaseReplication Protein ARPA1 protein, human

Identifiers

PMID21901111
PMCPMC3161930
OpenAlexW2030943082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.